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A B S T R A C T
We report a 36-year-old woman with primary hypothyroidism
revealed by postpartum amenorrhoea-galactorrhoea associated
with hyperprolactinaemia and suprasellar pituitary enlarge-
ment on magnetic resonance imaging (MRI). On thyroid
hormone replacement therapy all clinical, biochemical, radio-
logical and endocrine abnormalities disappeared. Hyperplasia
of pituitary thyrotrophs and/or lactotrophs seems to be
responsible for the pituitary enlargement seen on MRI.
I N T R O D U C T I O N
Amenorrhoea, galactorrhoea and hyperprolactinaemia in
a young woman usually suggests a prolactinoma of the
anterior pituitary.1 Hyperprolactinaemia is present in one-
third of primary hypothyroid patients.2-7 Less commonly,
galactorrhoea and amenorrhoea is associated with primary
hypothyroidism.2,5 Rarely, amenorrhoea, galactorrhoea
and hyperprolactinaemia in primary hypothyroid patients
are associated with an enlarged pituitary gland leading to
diagnostic confusion with prolactinomas.8-11
We report a patient with primary hypothyroidism associated
with postpartum galactorrhoea, amenorrhoea and pituitary
gland enlargement as well as her clinical course during
L-thyroxine replacement therapy.
C A S E  R E P O R T
A 36-year-old woman, gravida 2 para 2, was referred to
our hospital in 2001 for analysis of amenorrhoea and
galactorrhoea since her last pregnancy in 1997. The patient
had a normal pregnancy and delivery in December 1997.
After a nursing period of six weeks, secretion of milk
persisted associated with amenorrhoea. Serum prolactin
concentration (PRL) was 103 g/l (normal 0-20 g/l).
Thyroid function was not tested at that time. She was
treated with conventional doses of bromocriptine for nearly
twelve months, leading to cessation of galactorrhoea and
normal periods. After discontinuation of therapy all
symptoms returned. After a brief period of oral anticoncep-
tive therapy, during which periods were regular, the patient
discontinued this medication as well and was seen by a
gynaecologist in 2001 for amenorrhoea and galactorrhoea.
The external and internal genitalia were normal. On
examination bilateral galactorrhoea was confirmed. Again
prolactin was 103 g/l. Magnetic resonance imaging (MRI)
revealed a 14 x 20 x 12 mm pituitary macroadenoma
extending to the suprasellar cisterna without compression
of the chiasma (figure 1). With this information the patient
was sent to the department of endocrinology.
Typical clinical signs suggesting hypothyroidism were
noticed on physical examination. There was no palpable
thyroid tissue. Milk could easily be expressed from the
breasts. Thyroid function tests were consistent with primary
hypothyroidism. The serum free T4 (FT4) was 3.9 pmol/l
(normal 10.0-24.0 pmol/l) and thyroid stimulating hormone
(TSH) >75 mU/l (normal 0.40-4.00 mU/l). Basal serum
prolactin (PRL) was elevated: 103 g/l (normal 0-20 g/l).
Luteinising hormone (LH) was < 1 U/l and oestradiol (E2)
was <0.07 nmol/l. The remaining dynamic tests of the
hypothalamic-pituitary axis were normal, including
growth hormone and ACTH.
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Substitution therapy with L-thyroxine was started, gradually
increasing to 125 g daily. During the next ten months the
galactorrhoea resolved and menstrual bleeding resumed.
Serum free T4 concentration became normal at 18.7 pmol/l.
TSH and prolactin concentrations returned to normal, at
concentrations of 2.5 mU/l and 20 g/l respectively. LH
concentration was 4.5 U/l and E2 0.36 nmol/l. MRI of the
sellar region was repeated after six months of treatment.
MRI demonstrated a marked decrease in the size of the
pituitary mass within the sella turcica. After one year of
treatment with L-thyroxine repeated MRI showed normal
dimensions of the pituitary gland and the bony structures
surrounding it (figure 2).
D I S C U S S I O N
This case illustrates that primary hypothyroidism in a
female may present by amenorrhoea, galactorrhoea and
hyperprolactinaemia. Amenorrhoea appears to be caused
by suppression of the hypothalamic GnRH secretion by
prolactin leading to low gonadotropin and oestradiol levels.12
The cause of hyperprolactinaemia in primary hypothyroidism
is less clear. Several mechanisms have been proposed. At
least four factors may contribute to hyperprolactinaemia
in primary hypothyroidism. Firstly, the elevated prolactin
could be attributed to increased PRL secretion under the
influence of TRH, which stimulates TSH as well as PRL
secretion.2,13
Secondly, prolactin clearance may be decreased in
hypothyroid patients.14 Thirdly, a study by Foord et al.
demonstrated that cultured anterior pituitary cells from
hypothyroid rats have a reduced sensitivity to the inhibitory
action of dopamine and dopamine agonists on prolactin
production, possibly by a defect at the level of the dopamine
receptor or at the post receptor level.15,16 Fourthly, thyroid
hormone itself may also play an important role in the
cause of hyperprolactinaemia. Davis et al. noticed that 3,5,3’-
triiodothyronine reduces prolactin messenger RNA levels
in rodent pituitary cells.17 Decreased circulating thyroid
hormone levels might stimulate prolactin synthesis. The
pathophysiological mechanisms in primary hypothyroidism
that lead to hyperprolactinaemia might involve factors
acting on prolactin receptors as well as on prolactin gene
expression.
The pituitary enlargement in primary hypothyroidism
may be explained by lactotroph and/or thyrotroph hyper-
plasia;18-20 severity and duration of hypothyroidism being
of influence. In view of the potent negative regulation of
dopamine on prolactin cells, compression of the pituitary
stalk due to hyperplasia of the pituitary can also lead to a
moderate hyperprolactinaemia. In our patient this seems
to be unlikely as the other dynamic hypothalamic-pituitary
tests were normal.
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Figure 1 
MRI of the pituitary gland in a young woman with 
primary hypothyroidism before treatment with 
L-thyroxine showing a 14 x 20 x 12 mm pituitary 
mass extending to the suprasellar cistern (arrow)
Figure 2
MRI of the pituitary gland in a young woman with 
primary hypothyroidism after one year of treatment with
L-thyroxine showing normal dimensions of the pituitary
gland and the bony structures surrounding it
Hypothyroidism and hyperprolactinaemia with pituitary
enlargement can cause diagnostic difficulties. Coexistence
of primary hypothyroidism and a pituitary macroadenoma
as well as primary hypothyroidism associated with hyper-
prolactinaemia and pituitary enlargement should be taken
into account. The resolution of the pituitary enlargement
and the resumption of the menstrual cycle after replace-
ment therapy with L-thyroxine strongly argues against the
possibility of a coexisting macroadenoma and favours the
second possibility.
C O N C L U S I O N
In a female patient with amenorrhoea, galactorrhoea and
hyperprolactinaemia associated with enlargement of the
pituitary gland, primary hypothyroidism should always be
excluded as a possible cause.
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Table 1
The course of serum FT4, TSH, PRL, LH and E2 in a young woman with primary hypothyroidism before and after ten
months of treatment with L-thyroxine
FT4(PMOL/L ) TSH (MU/L) PRL (G/L) LH (U/L) E2 (NMOL/L)
Before 3.9 >75.0 103 <1 <0.07
After 18.7 2.5 20 4.5 0.36
